Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FGFR3 |
| Upstream (Parents) |
|---|
| (<<) BCL2A1 → FGFR3 |
| (<<) DHCR7 → FGFR3 |
| (<<) GBP2 → FGFR3 |
| (<<) HLA-G → FGFR3 |
| (<<) HMGA2 → FGFR3 |
| (<<) LRP5 → FGFR3 |
| (<<) ORM1 → FGFR3 |
| (<<) PTPRE → FGFR3 |
| (<<) RASSF1 → FGFR3 |
| (<<) RDX → FGFR3 |
| (<<) SULT1A1 → FGFR3 |
| (<<) SULT1A2 → FGFR3 |
| (<<) TIMP2 → FGFR3 |
| (<<) TSPO → FGFR3 |
| (<<) YWHAH → FGFR3 |
| Downstream (Children) |
|---|
| FGFR3 → CALB1 (>>) |
| FGFR3 → CRLF3 (>>) |
| FGFR3 → CXCL14 (>>) |
| FGFR3 → ID1 (>>) |
| FGFR3 → IL18 (>>) |
| FGFR3 → INHBA (>>) |
| FGFR3 → KCNK1 (>>) |
| FGFR3 → MAPK12 (>>) |
| FGFR3 → PITPNC1 (>>) |
| FGFR3 → RHOQ (>>) |
| FGFR3 → SMO (>>) |
| FGFR3 → SPINK1 (>>) |
| FGFR3 → STX12 (>>) |
